New EDC Tools Enable Even Faster Self-Serve Study Builds

By Ben Baumann

OpenClinica has been recognized by Everest Group as a Major Contender in the 2024 Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment, highlighting its unique combination of robust functionality and user-friendly design. Unlike many EDC platforms that require specialized programming expertise, OpenClinica empowers clinical data managers to independently build and manage complex studies through its intuitive Study Designer. Features like single-click publishing, real-time collaboration, and automated study calendaring allow teams to quickly adapt to protocol changes and streamline trial operations.

OpenClinica’s platform continues to evolve with enhanced participant engagement tools, such as a 21 CFR Part 11-compliant eConsent module, mobile-friendly forms, and seamless Apple Health data integration. Its advanced eCRF capabilities—real-time edit checks, dynamic logic, and cross-form data referencing—ensure high data quality and efficiency. Collaboration and compliance are further strengthened with version control, commenting tools, and automated audit trails. With these innovations, OpenClinica delivers a powerful yet accessible EDC solution, enabling faster, more efficient study builds without compromising data integrity or compliance, allowing clinical teams to focus on advancing research outcomes.